Showing results (1031-1040 of 1,586) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|October 26, 2022
Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric PatientsNicole W Kittler, Jazzmin C Williams, Margaret V Kudlinski, et al.
JAMA Dermatology|November 2, 2022
Follow-up of Patients With Keratinocyte Carcinoma: A Systematic Review of Clinical Practice GuidelinesSara Mirali, Evan Tang, Aaron M Drucker, et al.
JAMA Dermatology|October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) InitiativeYael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
JAMA Dermatology|September 14, 2022
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical TrialAnanta Khurana, Aastha Agarwal, Diksha Agrawal, et al.
JAMA Dermatology|September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical TrialJoel M Gelfand, Daniel B Shin, April W Armstrong, et al.
JAMA Dermatology|October 5, 2022
Apremilast in Recalcitrant Cutaneous Dermatomyositis: A Nonrandomized Controlled TrialCarole Bitar, Thien Ninh, Katherine Brag, et al.
JAMA Dermatology|October 6, 2021
Assessment of Clinical and Laboratory Use of the Cutaneous Direct Immunofluorescence AssayJulie D R Reimann, Sean P Moynihan, Thomas D Horn
JAMA Dermatology|May 16, 2019
Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018Raghav Tripathi, Harib H Ezaldein, Krithika Rajkumar, et al.
JAMA Dermatology|May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and SurvivalAnaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
JAMA Dermatology|May 2, 2019
Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous MelanomaLaura Calomarde-Rees, Rosario García-Calatayud, Celia Requena Caballero, et al.
Pageof 159